KYTX
Kyverna Therapeutics, Inc.
7.00$
-1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +79.4% | +62.4% | +25.0% | -15.7% | |
| – | -87.2% | +139.0% | +276.4% | +20.6% | |
| – | – | – | +129.5% | -113.7% | |
| – | -40.4% | -19.1% | +255.1% | -99.8% | |
| – | +993.6% | -37.7% | +1,731.6% | – | |
| – | +507.3% | +213.7% | +22.4% | -15.5% | |
| – | -83.6% | +389.2% | +480.0% | -58.1% | |
| – | -178.1% | – | – | -55.7% | |
| – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.